{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:19:07Z","timestamp":1783430347282,"version":"3.54.6"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Tuberculosis (TB) remains a major global health challenge, responsible for substantial morbidity and mortality. Understanding national epidemiological patterns, particularly in countries with large expatriate populations, is essential to update and guide both local and international TB control strategies. This study describes the epidemiology of TB in Qatar over an 8-year period (2016\u20132023).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort analysis using the Communicable Disease Center national TB registry. All individuals with confirmed\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      infection were included. Demographic characteristics, incidence, mortality, site of disease, and drug resistance patterns were included. Incidence rates were calculated using national population estimates and stratified by age, sex, nationality, and clinical form.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 6373 TB cases were reported during the study period. Annual incidence fluctuated between 20 and 37 per 100,000 population, consistently below both the global average and the World Health Organization End TB 2025 milestone target. A temporary spike was observed in 2021, possibly related to COVID-19 disruptions in health services and migration patterns. The majority of cases occurred in the 25\u201354 years age group. Males had consistently higher incidence rates than females. Non-Qataris accounted for the overwhelming majority of cases, particularly expatriates from high TB burden countries. The proportion of rifampicin-resistant or multidrug-resistant TB remained stable at 0.5%\u20131.8%, below the global average, with two cases of extensively drug-resistant TB identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>TB incidence in Qatar remains relatively low, with the burden falling disproportionately on working-age male expatriates from high-incidence countries. The findings highlight the importance of targeted screening, continuity of TB services during health system disruptions, and sustained surveillance of drug-resistant TB. These results provide insights relevant not only to Qatar but also to other low-incidence, high-migration countries striving to achieve global TB elimination goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_242_25","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:19:01Z","timestamp":1782857941000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of Tuberculosis in Qatar: Eight-year Retrospective Cohort Study"],"prefix":"10.4103","volume":"15","author":[{"given":"Joanne","family":"Daghfal","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-7985","authenticated-orcid":false,"given":"Sara","family":"Al Balushi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masautso","family":"Chaponda","sequence":"additional","affiliation":[{"name":"Department of Medicine, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Ghassan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraj","family":"Howady","sequence":"additional","affiliation":[{"name":"Department of Medicine, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Alsoub","sequence":"additional","affiliation":[{"name":"Department of Medicine, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Hashim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Al.Maslamani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1016\/S2214-109X(22)00085-7","article-title":"National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010-19: A data envelopment and stochastic frontier analysis","volume":"10","author":"Abou Jaoude","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"Suppl 1","key":"R6-20260707","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB \u2013 Latest developments in epidemiology, diagnostics and management","volume":"124","author":"Tiberi","year":"2022","journal-title":"Int J Infect Dis"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41256-025-00424-y","article-title":"Prevalence of Tuberculosis among migrants under national screening programs: A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2025","journal-title":"Glob Health Res Policy"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"102872","DOI":"10.1016\/j.tmaid.2025.102872","article-title":"Burden, clinical outcomes, and characteristics of tuberculosis in migrant populations in the middle East and North African region: A systematic review and meta-analyses","volume":"66","author":"Maatoug","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"100386","DOI":"10.1016\/j.jctube.2023.100386","article-title":"Association of Mycobacterium tuberculosis infection test results with risk factors for tuberculosis transmission","volume":"33","author":"Venkatappa","year":"2023","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12889-023-17495-6","article-title":"Global, regional and national trends in tuberculosis incidence and main risk factors: A study using data from 2000 to 2021","volume":"24","author":"Bai","year":"2024","journal-title":"BMC Public Health"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmy.ijmy_242_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:01:01Z","timestamp":1783429261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmy.ijmy_242_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_242_25","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}